The Manila Times

FDA Granted Hopstem’s hNPC01 for Chronic Ischemic Stroke Approval to Enter Phase 2/3 ...

Hopstem Biotechnology Inc. (hereinafter referred to as 'Hopstem'), a company dedicated to the development of induced ...